Imaging translation: Connecting discovery science to improved outcomes for patients

Speaker: Professor Graham Galloway

Bio: Professor Galloway is the Director of the Herston Imaging Research Facility (HIRF) and Director of Research at the Translational Research Institute (TRI). He was formerly the Chief Executive Officer of the National Imaging Facility from 2017 until 2021, and continues to engage internationally through Global BioImaging. Prof Galloway’s research is defined by finding innovative solutions to novel problems, of breaking new ground, of pushing the envelope of research using MR. His publications include the first human liver and heart spectra, novel pulse sequences for volume selection and water suppression and the first 3D FSE echo experiments. His role in all projects is characterised by his multidisciplinary background, which ensures that he is able to draw together these apparently disparate threads. He is committed to ensuring medical research is inclusive of all, across ethnic, economic, social and gender boundaries. Theranostics is an exciting new horizon and mental health is a challenge that we must do more to address.

Overview: Imaging is now recognised as an effective biomarker, and accepted by FDA and TGA. It is used to understand mechanisms, identify targets for therapy, assess efficacy and recognise side effects. Imaging in preclinical models is directly translatable to human imaging. In this presentation, I will showcase the imaging capability at HIRF that is available to put a spotlight on your research.